REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 50 filers reported holding REDHILL BIOPHARMA LTD in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -100.0% | 11,075 | -83.1% | 0.00% | – |
| Q3 2022 | $33,000 | -42.1% | 65,575 | 0.0% | 0.00% | – |
| Q2 2022 | $57,000 | -65.5% | 65,575 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $165,000 | -2.4% | 65,575 | 0.0% | 0.00% | – |
| Q4 2021 | $169,000 | +231.4% | 65,575 | +492.1% | 0.00% | – |
| Q3 2021 | $51,000 | -32.9% | 11,075 | 0.0% | 0.00% | – |
| Q2 2021 | $76,000 | – | 11,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 300 | $2,175 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |